Budget-driven cutbacks have altered two federal pillars of U.S. food safety. The Food and Drug Administration has paused its proficiency-testing program for laboratories that certify Grade “A” milk, leaving states and processors without a federal benchmark for detecting pathogens and drug residues. At the same time, the Department of Agriculture’s Food Safety and Inspection Service has withdrawn a rule that would have treated high-risk Salmonella strains in raw poultry as adulterants, ending the first major attempt in a decade to lower infection rates linked to chicken and turkey. The second Trump administration cites regulatory streamlining; industry groups welcome the moves. Public-health officials warn that raw-milk illnesses and multidrug-resistant Salmonella strains remain significant threats, especially as independent candidate Robert F. Kennedy Jr. campaigns to legalize interstate raw-milk sales. Absent federal backstops, states, processors and consumers must shoulder more responsibility for keeping milk and poultry safe.
Category: Health
How Federal, State, and Industry Checks Keep Milk Safe During an FDA Lab Pause
Federal officials have paused the Food and Drug Administration’s proficiency-testing program—the twice-a-year audit that checks whether milk laboratories around the country can still hit federally defined targets—while they move the work to a new site. The daily safeguards that actually decide whether a tanker can unload or a production lot can ship, however, remain fully in force. Processing plants continue to screen every load for drug residues, run microbial counts after pasteurization and hold product until results clear. State public-health labs still pull independent samples, can order recalls and feed data to the national residue database. Because those two front-line layers are unchanged, food-safety scientists and regulators agree that the risk to consumers has not increased despite the temporary gap in federal audit rounds.
USDA Drops Salmonella Limits After Big Poultry Donation
Millions of Americans already battle salmonella each year, yet a long-promised USDA rule designed to cut infections by a quarter has been shelved after an unprecedented $5 million inauguration donation from one of the nation’s largest chicken processors. Internal records, lobbying filings and CDC data reveal how economic influence, regulatory hesitation and antibiotic-resistant bacteria converged to keep stricter standards off the books—leaving consumers, doctors and watchdogs asking who really protects the dinner plate when public health and corporate power collide.